Trial intelligence / Profile preview

Bupropion in Binge Drinking

NCT03169244Phase 2Completed

Sponsor
University of North Carolina at Chapel Hill
Start
Sep 2017
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bupropion in alcohol use disorder (AUD), sponsored by University of North Carolina at Chapel Hill. Started Sep 2017; status: completed.

02

Drugs

bupropion
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT03169244.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03169244.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call